Korro Bio, Inc.·4

Jun 12, 5:25 PM ET

FORMELA JEAN FRANCOIS 4

4 · Korro Bio, Inc. · Filed Jun 12, 2024

Insider Transaction Report

Form 4
Period: 2024-06-11
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-11+5,1905,190 total
    Exercise: $42.19Exp: 2034-06-10Common Stock (5,190 underlying)
Footnotes (2)
  • [F1]The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date.
  • [F2]The Reporting Person is a member of Atlas XI and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas Venture Life Science Advisors, LLC. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4